Related Experiment Videos
Methylbromide: carcinogenic effects in the rat forestomach
Toxicology and Applied Pharmacology
|February 1, 1984
Summary
Methylbromide (MB) is carcinogenic in rats, causing forestomach tumors and hyperplasia at high doses. Lower doses showed reduced hyperplasia, while the lowest dose had no effect.
Area of Science:
- Toxicology
- Carcinogenesis
- Gastrointestinal Pathology
Background:
- Methylbromide (MB) is a widely used fumigant with potential health risks.
- Understanding the long-term effects of MB exposure is crucial for public health and environmental safety.
Purpose of the Study:
- To evaluate the carcinogenic potential of methylbromide (MB) in a rodent model.
- To determine dose-dependent effects of MB on the forestomach epithelium.
Main Methods:
- Rats were administered methylbromide (MB) via oral gavage in arachis oil for 90 days.
- Dose groups included 50, 10, 2, and 0.4 mg MB/kg body weight.
- Histopathological examination of forestomach tissue was performed.
Main Results:
- The highest dose (50 mg/kg) resulted in squamous cell carcinomas in 13/20 rats.
- Marked diffuse hyperplasia of the forestomach epithelium was observed in the highest dose group.
- Hyperplasia was also observed at lower incidences with 10 and 2 mg/kg doses; 0.4 mg/kg showed no effects.
Conclusions:
- Methylbromide (MB) demonstrates clear carcinogenic activity in the rat forestomach at 50 mg/kg.
- MB induces dose-dependent hyperplasia of the forestomach epithelium.
- These findings highlight the risks associated with methylbromide exposure.